Position in ROIV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,539
+$769 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#444
of 494 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $2,753,792 across 36 Biotechnology names. ROIV ranks #23 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
|
240,427 | $1,115,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,199 | $954,815 | |
| 3 | AVXL |
Anavex Life Sciences Corp.
|
48,100 | $124,579 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
1,269 | $69,718 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
5,754 | $50,376 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 | |
| 8 | INSM |
INSMED Inc
|
414 | $44,140 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,539 | 100 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,770 | 100 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,170 | 100 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,513 | 100 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,600 | 142 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,432 | 142 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,183 | 100 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,154 | 100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,057 | 100 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,054 | 100 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||